<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39464954</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2249-4863</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of family medicine and primary care</Title><ISOAbbreviation>J Family Med Prim Care</ISOAbbreviation></Journal><ArticleTitle>A cross-sectional survey of ocular problems after COVID-19 infection among healthcare workers at a teaching hospital.</ArticleTitle><Pagination><StartPage>3644</StartPage><EndPage>3646</EndPage><MedlinePgn>3644-3646</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jfmpc.jfmpc_785_24</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The COVID-19 pandemic was caused by severe acute respiratory syndrome coronavirus-2 (SARS-COV2). The impact of the pandemic is becoming more apparent now on various tissues and body organs. Limited knowledge is present about the characteristics, duration, and long-term sequelae of ocular problems post-COVID-19 infection. The purpose of the present study was to evaluate and analyze the ocular problems occurring in healthcare workers after COVID-19 infection.</AbstractText><AbstractText Label="MATERIAL AND METHOD" NlmCategory="UNASSIGNED">This was a cross-sectional survey study conducted in the Department of Ophthalmology, Patna Medical College and Hospital, Patna. The participants were healthcare workers who were exposed to COVID-19 infection ≥6 months back. A questionnaire was prepared. Responses were evaluated and analyzed. Patient consent and institutional committee permission were taken as per norms.</AbstractText><AbstractText Label="RESULT" NlmCategory="UNASSIGNED">A total of 210 healthcare workers who were infected with COVID-19 &gt;6 months back responded with complete answers. The maximum number of respondents was between the ages of 31 and 60 (73.3%). The pre-covid ocular problems were present in 25% of the participants, especially in those having chronic diseases (such as diabetes, hypertension, or both). Post-ocular problems were faced by 60% of the participants, which was significant (<i>P</i> &lt; 0.01). Dry eye, itching, and foreign body sensations were present in 60% of those facing ocular problems (<i>P</i> &lt; 0.01). Ocular surface manifestations were more common.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">A knowledge, understanding, and awareness about ocular problems and their long-term sequelae in post-COVID-19-infected patients will help in early diagnosis and better management of such patients.</AbstractText><CopyrightInformation>Copyright: © 2024 Journal of Family Medicine and Primary Care.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Santosh Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Patna Medical College, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Naveen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Patna Medical College, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumari</LastName><ForeName>Arti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Nalanda Medical College, Patna, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Anant Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Bhagwan Mahavir Institute of Medical Sciences, Pawapuri, Nalanda, Bihar, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Family Med Prim Care</MedlineTA><NlmUniqueID>101610082</NlmUniqueID><ISSNLinking>2249-4863</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ocular problems</Keyword><Keyword MajorTopicYN="N">ocular surface</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39464954</ArticleId><ArticleId IdType="pmc">PMC11504770</ArticleId><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_785_24</ArticleId><ArticleId IdType="pii">JFMPC-13-3644</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al. ocular manifestation and clinical characteristies of 535 cases of COVID-19 in Wuhan China. A cross sectional study. Acta Ophthelmid. 2020;98:e951–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276826</ArticleId><ArticleId IdType="pubmed">32421258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patient with corona virus disease 2019. COVID-19 in Hubei province China. JAMA Ophthalmol. 2020;138:575–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110919</ArticleId><ArticleId IdType="pubmed">32232433</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri A, Oliverio GW, Mancus OG, Giuffrida A, Guarneri C, Venanzi Rullo E, et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020;10:20178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677531</ArticleId><ArticleId IdType="pubmed">33214658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y, Wang K, Zhu Y, Lyu D, Yu Y, Li S, et al. Ocular manifestation in COVID-19 patients: A systematic review and metaanalysis. Travel Med infect Dis. 2021;44:102191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574127</ArticleId><ArticleId IdType="pubmed">34763068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho D, Low R, Tong L, Gupta V, veer raghvah A, Agrawal R. COVID-19 and the ocular surface: A review of transmissions and manifestation. Ocul Immunol Inflamm. 2020;28:726–34.</Citation><ArticleIdList><ArticleId IdType="pubmed">32543262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, Yu W, Xia j, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS- COV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020;98:e649–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267628</ArticleId><ArticleId IdType="pubmed">32336042</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A, et al. Ocular manifestation of COVID-19: A systematic review and meta-analysis. J Ophtalmic Vis Res. 2021;16:103–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841281</ArticleId><ArticleId IdType="pubmed">33520133</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltanis, Zardi M, Ahmadi SE, Zarandi B, Hosseini Z, Akhavan Rezayat S, et al. Pooled prevalence estimate of ocular manifestation in COVID-19 patients: A systematic review and Metaanalysis. Iran J Med Sci. 2022;47:2–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743370</ArticleId><ArticleId IdType="pubmed">35017772</ArticleId></ArticleIdList></Reference><Reference><Citation>McHarg M, Wang Y, Yakin M, Zeleny A, Caplash S, et al. Ocular symptoms in COVID-19 infection: A survey study. J Ophthalmic Inflamm Infect. 2022;12:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9765365</ArticleId><ArticleId IdType="pubmed">36538113</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K, Jaki Mekjarie P, Vidovic Valentincic N, Petrovski G, Petrovic MG. An update on COVID-19 related ophtalamic manifestations. Ocul immunol Inflamm. 2021;29:684–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33826465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>